Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-009120
Filing Date
2025-06-12
Accepted
2025-06-12 13:58:00
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-69480.html 4  
1 PRIMARY DOCUMENT marketforms-69480.xml 4 4698
  Complete submission text file 0001214659-25-009120.txt   6187
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 201 MAIN STREET, SUITE 1900 FORT WORTH TX 76102
Business Address
Cochran John (Reporting) CIK: 0001406773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 251042401